Skip to Main Content

Paper Details

Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML).
Leuk Res
22
2018
Author NameAffiliation
Bruno C MedeirosStanford University
  • 1 - 1

Datasets

Release 1.2